Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk
Yaohua Yang(University of Virginia), Douglas A. Levine(New York University), Linda S. Cook, Ellen L. Goode(Mayo Clinic in Arizona), Peter A. Fasching(Universitätsklinikum Erlangen), Graham G. Giles(The University of Melbourne), Claus Høgdall(Copenhagen University Hospital), Line Bjørge(Haukeland University Hospital), Jenny Chang‐Claude(Universität Hamburg), Florian Heitz(Kliniken Essen-Mitte), Linda E. Kelemen(Medical University of South Carolina), Anna DeFazio(The University of Sydney), Thilo Dörk(Hannover Re (Germany)), Bingshan Li(Vanderbilt University), Joe Dennis(University of Cambridge), Estrid Høgdall(University of Copenhagen), Susanne K. Kjær(Copenhagen University Hospital), Ian Campbell(The University of Sydney), Marc T. Goodman(Cedars-Sinai Medical Center), Andrew Berchuck(General Marble (Greece)), Rosalind Glasspool(Institut Bergonié), Anita Koushik(Université de Montréal), Lambertus A. Kiemeney(Radboud University Nijmegen), Simon A. Gayther(The University of Texas Health Science Center at Houston), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Javier Benı́tez(Spanish National Cancer Research Centre), Xiang Shu(Memorial Sloan Kettering Cancer Center), Renée T. Fortner(Norwegian Institute of Public Health), Lang Wu(University of Hawaiʻi at Mānoa), Daniel W. Cramer(Brigham and Women's Hospital), Holly R. Harris(Fred Hutch Cancer Center), Susana Banerjee(Royal Marsden NHS Foundation Trust), Siddhartha Kar(University of Cambridge), Jennifer A. Doherty(Cancer Prevention Institute of California), Hoda Anton‐Culver(University of California, Irvine), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Beth Y. Karlan(University of California, Los Angeles), David G. Huntsman(BC Cancer Agency), Jacek Gronwald(International Hereditary Cancer Center), Fei Ye(University of Miami), Kexin Chen(Harbin University of Science and Technology), Michelle A.T. Hildebrandt(The University of Texas MD Anderson Cancer Center), Alicia Beeghly‐Fadiel(University of Helsinki), Nhu D. Le(BC Cancer Agency), Digna Velez Edwards, Yingchang Lu(National Taiwan University Hospital), Qiuyin Cai(Vanderbilt University), Xiao-Ou Shu(Vanderbilt University Medical Center), Ralf Bützow(Helsinki University Hospital)
Cited by 62
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k